Organization | Sisli Hamidiye Etfal Training and Research Hospital

Sisli Hamidiye Etfal Training and Research Hospital Report issue

Academic/Hospital Phase 4

Founded: Istanbul Turkey (1899)

Organization Overview

First Clinical Trial

2007

NCT02002078

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Sisli Etfal | Sisli Etfal training and research hospital | Sisli Etfal Training & Research Hospital | Sisli Hamidiye Etfal Research and Training Hospital | Sisli Hamidiye Etfal Training and Research Hospital | Şişli Hamidiye Etfal Training and Research Hospital

Active Ingredients

Drugs in Phase 4 Trials (13)

bupivacaine (Exparel) (2 trials)

clavulanate (Augmentin) (1 trial)

dexmedetomidine (precedex) (1 trial)

follitropin alfa (1 trial)

lactobacillus reuteri (1 trial)

levobupivacaine (chirocaine) (1 trial)

lutropin alpha (luveris) (1 trial)

methylprednisolone (medrol) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

scopolamine (transderm scop) (1 trial)

sodium chloride (1 trial)

xylo-pentane-1,2,3,4 5-pentol (1 trial)

Drugs in Other Trials (6)

cobalamin (1 trial)

folic acid (1 trial)

heparin (liquaemin) (1 trial)

platelet rich plasma (1 trial)

sevoflurane (ultane) (1 trial)

sodium bicarbonate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diarrhea (Phase 4)

Esophageal Diseases (Phase 4)

Infertility (Phase 4)

Pain, Postoperative (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 13
# of Trial APIs: 19